EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
International Stem Cell Corp. (ISCO) EBITDA Margin data is not available.
| Income Statement Financials | |
$2.45M |
|
$0.07M |
|
$0.93M |
|
$1.52M |
|
$2.28M |
|
$0.17M |
|
$-0.04M |
|
$0.13M |
|
$0.13M |
|
$0.13M |
|
$0.13M |
|
$0.13M |
|
$0.13M |
|
$0.17M |
|
$0.22M |
|
8.00M |
|
8.00M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$3.84M |
|
$0.23M |
|
$1.71M |
|
$5.55M |
|
$4.94M |
|
-- |
|
$4.50M |
|
$9.44M |
|
$-3.90M |
|
$-4.58M |
|
$-3.90M |
|
8.00M |
|
| Cash Flow Statement Financials | |
$-0.07M |
|
$-0.04M |
|
$-0.20M |
|
$1.23M |
|
$0.92M |
|
$-0.31M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
62.12% |
|
6.82% |
|
6.82% |
|
|
EBITDA Margin |
-- |
5.27% |
|
2.74% |
|
$-0.11M |
|
-- |
|
-- |
|
-- |
|
0.44 |
|
0.60 |
|
2.22 |
|
40.49 |
|
-3.31% |
|
-2.82% |
|
2.33% |
|
-3.31% |
|
$-0.49 |
|
$-0.01 |
|
$-0.01 |
|